Archive for the ‘research’ Category

4,376 Treated, Zero Deaths: What This Clinic Got Right About Early COVID Care

https://imahealth.substack.com/p/4376-treated-zero-deaths-what-this?

4,376 Treated, Zero Deaths: What This Clinic Got Right About Early COVID Care

The Independent Journal of Medicine is currently free to access for all. Download the latest issue today!

Independent Medical Alliance
May 09, 2025

A newly published review in the Journal of Independent Medicine presents compelling data from a southern California clinic that treated thousands of COVID-19 patients during the height of the pandemic—with outcomes that significantly outperformed regional and national trends. Among 3,962 patients with mild COVID-19 who received early outpatient treatment, there were zero deaths and only two hospitalizations (0.05%).

The review, authored by IMA Senior Fellow Dr. Brian Tyson and colleagues at All Valley Urgent Care (AVUC), documents a pragmatic, real-world approach to care built on clinical vigilance, close patient follow-up, and the strategic use of repurposed medicines. The results add weight to a growing body of observational data supporting early intervention as a critical factor in preventing COVID-19 progression and death.  (See link for article)

________________

**Comment**

It’s important to note the study was completed YEARS ago but was repeatedly rejected by bought-out journals.  The only reason the information is peer reviewed, published, and seeing the light of day is due to the new Journal of Independent Medicine. 

COVID was the red pill many doctors and researchers needed, and the silver lining is journal, media, government, and medical corruption has been exposed.

Every California patient in the clinic received empiric treatment at the time of presentation—often before test results were available—and was monitored closely through in-person or telemedicine follow-up.

Treatments included combinations of ivermectin, hydroxychloroquine, azithromycin, doxycycline, corticosteroids (both oral and injectable), monoclonal antibodies, and nutraceuticals such as zinc, quercetin, vitamin C, and vitamin D3.T

The California clinic stands in contrast to centralized public health response that typically discouraged outpatient care altogether, focusing instead on late-stage hospitalization and experimental pharmaceutical interventions. While new, on-patent expensive drugs were prioritized, the California physicians pursued cost-effective, repurposed and natural options that could be widely deployed.

For more:

Category:

Activism, research, Supplements, Treatment, Viruses

Fort Detrick Bio-Lab Halts Operations After Murder Attempt

Rewind to the 2001 anthrax letter attacks.

Anthrax spores laced in envelopes killed 5 people and infected 17 others – mainly politicians who opposed the Patriot Act and folks at news media offices.  It was staged to appear to be the work of Iraqi or Islamic agents but the FBI quickly discovered this to be false and that it was an inside job.  It took years but eventually the FBI announced Fort Detrick scientist Bruce Edwards Ivins was the perp.  

Why?

His precious anthrax vaccine program was cancelled, so he figured he would have  to teach the world just how much we needed his vaccine.

Fort D has a long history.

Fort Detrick had a program to study the use of arthropods for spreading anti-personnel bioweapon agents. Willy Burgdorfer was a key member of this project team who worked on weaponizing ticks and who teamed up with fellow tick expert James Oliver to develop ways to mass produce infected ticks so that they could be dropped from airplanes on enemy territory. These claims are backed up by interviews with these scientists, as well as with extensive government documentation from multiple reliable sources, all listed in Kris Newby’s book.

Present day……

https://sharylattkisson.substack.com/p/nih-halts-operations-at-us-biolab

NIH Halts Operations at US Biolab After Shocking Sabotage Incident, Sparking Safety Concerns

Dr. Jay Bhattacharya made the announcement on X

 
Sharyl Attkisson
 

May 8, 2025

Article Excerpts:

Bhattacharya revealed the decision in a detailed thread on his X account    (@NIHDirector_Jay).

He explained that he learned a contractor at the lab deliberately cut a hole in a co-worker’s biocontainment suit during a personal dispute, compromising critical safety protocols.

The incident, reportedly happened in early March but Bhattacharya says he did not learn of it until weeks later.  (See link for article)

_______________

**Comment**

Seems history keeps repeating itself…..

Sadly, legacy media is making this political rather than reporting facts.

  • The anthrax crime and the latest incident are part of a broader pattern of safety lapses that have existed for years. 
  • Richard Ebright, a prominent microbiologist, warned about the lack of psychological screening for researchers citing a case involving a murder suspect who worked with the plague bacterium, Yersinia pestis, at a similar facility.
  • In 2022 Ebright warned that NIAID’s planned experiments at Fort Detrick involved monkeypox, where researchers intended to combine a globally circulating strain with a more lethal variant. The project bypassed mandatory risk-benefit reviews.
  • In 2025 NIAID Director Jeanne Marrazzo was dismissed partly due to her failure to address ongoing safety concerns at the facility.
  • Lab director, Connie Schmaljohn ws placed on administration leave following the March incident after failing to report it up the chain of command promptly, causing delays in addressing the breach.  
  • This website reported on the shut down of the Fort Detrick lab in 2019 after a failed safety inspection.  The fact the corrupt CDC sent a cease and desist order shows how just how bad it is.

Category:

Activism, research, Ticks

GLA Grantee Publishes Two Studies in Leading Journal

https://www.globallymealliance.org/news/gla-grantee-publishes-two-pivotal-studies-in-leading-journal?

GLA Grantee Publishes Two Pivotal Studies in Leading Journal

by Admin at Global Lyme Alliance on April 23, 2025

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >GLA Grantee Publishes Two Pivotal Studies in Leading Journal</span>

April 23, 2025–Global Lyme Alliance (GLA) is proud to announce that Dr. Brandon Jutras, a GLA grantee and researcher at Northwestern University, has published two pivotal studies in Science Translational Medicine, which were selected for the journal’s cover, highlighting the significance and innovation of the work.

The twin studies were published online today. In the first study, Dr. Jutras and his team demonstrate that fragments of the Borrelia burgdorferi cell wall, called peptidoglycan, can persist in the livers of mice and in the joints of patients with Lyme arthritis. These bacterial remnants may act as a trigger for continued inflammation even after the infection has been treated. 

In the second study, the researchers explore the use of piperacillin, a beta-lactam antibiotic, as a novel therapeutic strategy in Lyme disease. While piperacillin was highly effective at killing B. burgdorferi in both in vitro models and mice, it was shown to cause less disruption to the gut microbiome than other commonly used antibiotics, an important advantage in reducing unintended harm to beneficial bacteria.

“The new publications represent a significant step forward in Lyme disease research, at a time when the geographic range of Lyme disease–transmitting ticks is expanding and more individuals are at risk of both acute infection and long-term complications” said GLA’s Chief Scientific Officer, Armin Alaedini, PhD. “Dr. Jutras’s research provides important insights into how bacterial remnants may contribute to persistent inflammation and points to promising new directions for both diagnosis and therapeutic intervention.”

GLA’s funding of these studies is part of its ongoing mission to advance innovative, high-impact science that can transform outcomes for the millions affected by Lyme and other tick-borne diseases.

About Global Lyme Alliance:
Global Lyme Alliance is the leading Lyme disease nonprofit dedicated to fighting Lyme disease through research, awareness, and patient support.

Media Contact:
Please email info@gla.org for media inquiries.

Publications:

www.science.org/doi/10.1126/scitranslmed.adr9091 

www.science.org/doi/10.1126/scitranslmed.adr2955

______________

**Comment**

I hate to let the air out of the balloon but this is not new news.  Knowing that bacterial fragments can cause inflammation has been studied ad nauseum:

When is persistent infection going to be studied?

We need a redo regarding Lyme/MSIDS research.  It’s all based upon a false premise by those with conflicts of interest:

Category:

Lyme, research, Treatment

Charting a Path Towards New Treatments for Chronic Lyme Disease

https://www.lymedisease.org/charting-a-path-towards-new-treatments-for-chronic-lyme-disease/

Charting a path towards new treatments for chronic Lyme disease

Last year, the National Academies of Science, Engineering and Medicine (NASEM) convened a committee of experts to review the research on chronic Lyme disease and figure out what it would take to develop better treatments.

Now, that committee has completed its report, entitled Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses.

Click here to download a copy of the report.

On May 9, NASEM will host a public webinar explaining the report and answering questions about it.

Click here to register for the webinar.

_______________

**Comment**

I haven’t read this sucker yet – it’s 253 pages, but I’ve become so jaded with research for tick-borne illness that I’m dreading it already.

Until we start OVER, and I mean from square one, research is all tainted and based on false premises.  Don’t believe me?  Listen to Willy himself:

http://

Willy Burgforfer, Ph.D. Lyme Disease ‘Discoverer’

Category:

Lyme, research

Foreign Gain-of-Function Research Banned? Nope – It’s Expanding

According to attorney Tom Renz, the scuttle that dangerous ‘gain of function’ research was recently banned due to an Executive Order, is false.  Rather, it’s codified and allowed under new regulation.  It’s all good if you are compliant with current regulation.

“Gain of Function” has now been legitimized and sanctioned.  Far from being banned.

It’s all there in purple crayon amongst the legalese in the document, “Improving the Safety and Security of Biological Research.” 

So keep this in mind when you read:

https://www.thefocalpoints.com/p/breaking-trump-bans-foreign-gain

BREAKING: Trump Bans Foreign Gain-of-Function Research — U.S. Experiments Paused

The executive order halts federal funding for dangerous virus experiments overseas and temporarily suspends high-risk U.S. research involving infectious pathogens and toxins.

ByNicolas Hulscher, MPH
Article Excerpts:

President Donald Trump signed an executive order today titled, IMPROVING THE SAFETY AND SECURITY OF BIOLOGICAL RESEARCH, halting all federal funding for dangerous gain-of-function research in China, Iran, and other countries lacking adequate oversight. The order also suspends federally funded research involving infectious pathogens and toxins within the United States until a new, enforceable oversight policy is developed.

For the first time, the U.S. government is directing agencies to track and regulate high-risk bioengineering activities outside federal funding channels — a move that could close major loopholes exploited in past pandemic-related experiments.  (See link for article and video)

______________

For more:

Regarding Wisconsin:

Category:

Activism, research